A detailed history of Ferguson Shapiro LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ferguson Shapiro LLC holds 5,880 shares of BMY stock, worth $338,982. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,880
Previous 5,073 15.91%
Holding current value
$338,982
Previous $210,000 44.76%
% of portfolio
0.18%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$39.66 - $51.75 $32,005 - $41,762
807 Added 15.91%
5,880 $304,000
Q1 2024

Apr 10, 2024

BUY
$47.98 - $54.4 $243,402 - $275,971
5,073 New
5,073 $275,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ferguson Shapiro LLC Portfolio

Follow Ferguson Shapiro LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Shapiro LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Shapiro LLC with notifications on news.